Dr. Jonathan Gerber of UMass Memorial and UMass Medical School discusses the plasma registry used to help treat COVID-19 patients.
Also discussed are how plasma treatments are progressing, where the plasma registry fits in the development of COVID-19 treatments and where we stand in the search for an effective treatment.
To find out information about how to become a part of the UMass Medical School plasma registry click here.